Notably, depletion of FUNDC1 in patients with cervical cancer, where high levels of FUNDC1 are associated with a poor prognostic outcome, significantly enhances cell sensitivity to cisplatin and ionizing radiation [109]. This evidence concerns the gene FUNDC1 and cervical cancer.